Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
LifeStance Health Group, Inc. Market Cap
The LifeStance Health Group, Inc. (LFST) share price is expected to increase by 28.4% over the next year. This is based on calculating the average 12-month share price estimate provided by 2 stock analysts who have covered LFST. Price targets range from $7.00 at the low end to $10.00 at the high end. The current analyst consensus for LFST is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
About 2 Wall Street analysts have assigned LFST 1 buy ratings, 0 hold ratings, and 1 sell ratings. This means that analysts expect LifeStance Health Group, Inc. to perform worse than the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on LFST. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| stephanie davis Barclays | Sell | $7.0 | initiatedcoverage | Jan 2, 2024 |
| craig hettenbach Morgan Stanley | Buy | $10.0 | maintained | Nov 30, 2023 |
| lisa gill J.P. Morgan | Hold | $8.0 | maintained | Nov 17, 2023 |
| gary taylor TD Cowen | Hold | $6.0 | maintained | Nov 13, 2023 |
| jamie perse Goldman Sachs | Hold | None | maintained | Nov 8, 2023 |
| kevin caliendo UBS | Hold | $10.0 | maintained | May 12, 2023 |
| ricky goldwasser Morgan Stanley | Buy | $10.0 | maintained | May 11, 2023 |
| brian tanquilut Jefferies | Buy | $7.25 | initiatedcoverage | Nov 7, 2022 |
| stephanie wissink Jefferies | Buy | $18.0 | maintained | Apr 28, 2022 |
| ryan daniels William Blair | Buy | None | initiatedcoverage | Jul 6, 2021 |
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform, as well as offers patients care virtually through its online delivery platform or in-person at its centers in 33 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
When did it IPO
2021
Staff Count
6,418
Country
United States
Sector/Industry
Healthcare/Medical Care Facilities
CEO
Mr. Kenneth Alan Burdick
Market Cap
$2.51B
In 2023, LFST generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that LFST's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
BMBL-USD
$13.1
NTLA-USD
$27.74
PRVA-USD
$20.93
PINC-USD
$21.34
$51.91
$16.01
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
